13F-HR filed by Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 90 holding rows worth $746,583,161.
- Accession
- 0001420506-24-001560
- Filer
- CIK 1777015
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 90 entries on the cover page, a total value of $746,583,161 stated on the cover page (in dollars after the unit check, H1), rows summing to $746,583,161 with VALUE read as dollars as filed, 13F file number 028-19992. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation | 101137107 | COM | 551,592 | $42,478,100 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 179,305 | $36,183,749 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 111,381 | $35,480,418 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 31,654 | $28,658,899 | dollars as filed | |
| COOPER COS INC | 216648501 | COM | 308,398 | $26,923,145 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 148,927 | $19,811,759 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 446,416 | $19,249,458 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 694,178 | $18,763,631 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 296,739 | $17,854,786 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 156,855 | $17,784,220 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 68,167 | $15,931,310 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 115,170 | $15,855,454 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 27,751 | $15,037,157 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 721,373 | $13,951,354 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 185,028 | $12,672,568 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 121,913 | $12,667,980 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 2,409,599 | $12,578,107 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 908,822 | $12,523,567 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 100,000 | $12,380,000 | dollars as filed | put |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 600,698 | $12,332,330 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 647,142 | $12,082,141 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 37,056 | $11,615,944 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 150,191 | $11,340,922 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 30,037 | $11,223,325 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 535,063 | $10,829,675 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 574,517 | $10,347,051 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 474,679 | $9,906,551 | dollars as filed | |
| QIAGEN NV | N72482149 | COMMON STOCK-FO | 234,267 | $9,626,031 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 195,567 | $9,416,551 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 198,627 | $9,077,254 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 852,416 | $8,907,747 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 156,843 | $8,656,165 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 595,389 | $8,609,325 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 125,000 | $8,576,250 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 38,014 | $8,564,554 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 200,000 | $8,306,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 209,290 | $8,160,217 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 969,892 | $7,972,512 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 161,705 | $7,706,860 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 256,307 | $6,423,053 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 141,375 | $6,332,186 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 415,535 | $6,328,598 | dollars as filed | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 76,079 | $6,294,016 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 277,895 | $6,049,774 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 353,942 | $5,751,558 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 876,268 | $5,713,267 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 289,841 | $5,506,979 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 80,271 | $5,378,157 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 447,620 | $5,366,964 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,148,307 | $5,362,594 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 378,289 | $5,318,743 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,792,740 | $5,252,728 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 502,463 | $4,984,433 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 525,000 | $4,725,000 | dollars as filed | |
| PERFORMANT HEALTHCARE INC | 71377E105 | COM | 1,623,199 | $4,707,277 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 85,159 | $4,668,416 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 274,465 | $4,605,523 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 209,475 | $4,539,323 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 101,224 | $4,450,819 | dollars as filed | |
| AVID BIOSERVICES INC | 05368M106 | COM | 621,091 | $4,434,590 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 100,000 | $4,110,000 | dollars as filed | |
| FORTREA HLDGS INC COMMON STOCK | 34965K107 | Stock | 152,769 | $3,565,628 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 125,161 | $3,331,786 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 42,888 | $3,253,484 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 180,320 | $3,207,893 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 1,160,022 | $2,679,651 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 45,152 | $2,671,644 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 390,270 | $2,657,739 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 135,376 | $2,600,573 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,144,646 | $2,541,114 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 400,448 | $2,474,769 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 216,822 | $2,434,911 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 176,377 | $2,329,940 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 153,015 | $1,978,484 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 126,042 | $1,818,786 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 133,325 | $1,733,225 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 326,845 | $1,601,541 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 252,072 | $1,325,899 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 150,192 | $1,112,923 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 20,372 | $1,079,920 | dollars as filed | |
| AKOYA BIOSCIENCES INC COM | 00974H104 | Stock | 375,536 | $878,754 | dollars as filed | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 253,197 | $833,018 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 401,518 | $738,793 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 345,206 | $680,056 | dollars as filed | |
| Reviva Pharmaceuticals Holdings Inc | 76152G100 | Common Stock | 504,600 | $645,888 | dollars as filed | |
| AUGMEDIX INC | 05105P107 | COM | 566,845 | $498,824 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 806,616 | $467,837 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 97,816 | $459,735 | dollars as filed | |
| ALPHA TEKNOVA INC | 02080L102 | COMMON STOCK | 296,652 | $406,413 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 100,830 | $226,868 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-001560 | this filing | 2024-08-14 | acceptance time not in the bulk data set |